Innova Captab Ltd
INNOVACAP
Company Profile
Business description
Innova Captab Ltd is an integrated pharmaceutical company in India and is engaged in research and development, manufacturing, drug distribution, marketing, and exports. Company business includes (i) a contract development and manufacturing organization (CDMO) business providing manufacturing services to Indian pharmaceutical companies, (ii) a domestic branded generics business, and (iii) an international branded generics business.
Contact
Plot No.320
Industrial Area, Phase-1
PanchkulaHR134113
INDT: +91 1724194500
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
1,950
Stocks News & Analysis
stocks
Our top ASX picks in every sector
These companies are our favourite choices for investors wanting to boost Aussie equity exposure.
stocks
Tesla: Shares fall as deliveries come in below consensus
Long-term growth less reliant on auto sales.
stocks
Will Australia’s dwindling fuel supplies impact this share?
Australia’s petrol reserves have dropped from 60 to 35 days.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,921.20 | 21.50 | 0.24% |
| CAC 40 | 7,908.74 | 53.65 | -0.67% |
| DAX 40 | 22,921.59 | 246.49 | -1.06% |
| Dow JONES (US) | 46,455.60 | 214.28 | -0.46% |
| FTSE 100 | 10,348.79 | 87.50 | -0.84% |
| HKSE | 25,116.53 | 177.50 | -0.70% |
| NASDAQ | 21,871.95 | 124.39 | -0.57% |
| Nikkei 225 | 53,429.56 | 15.88 | 0.03% |
| NZX 50 Index | 13,069.66 | 243.79 | 1.90% |
| S&P 500 | 6,587.21 | 24.62 | -0.37% |
| S&P/ASX 200 | 8,728.80 | 43.80 | 0.50% |
| SSE Composite Index | 3,919.29 | 29.27 | -0.74% |